McCormack P M, Bains M S, Beattie E J, Martini N
Chest. 1978 Feb;73(2):163-6. doi: 10.1378/chest.73.2.163.
Resection of pulmonary metastases in osteogenic sarcoma has been reported by us to result in a five-year survival rate of 27 percent. A later report of surgical management of pulmonary metastases from all types of sarcomas showed a five-year survival rate of 26%. This report reviews the experience with 188 patients treated surgically for pulmonary metastasis from a variety of carcinomas, demonstrating that a similar rate of survival is obtainable by surgical excision of these metastases. A total of 188 patients underwent 242 thoractomies for metastatic pulmonary carcinomas. The most frequent sites of origin were the colon, melanoma, breast, and testicular carcinoma. Surgical treatment of these metastases is justified when the following criteria are adhered to: (1) primary site controlled or controllable; (2) no extrapulmonary metastatic sites demonstrable; (3) good surgical risk; and (4) no effective treatment available by nonsurgical means.
我们曾报道，骨肉瘤肺转移灶切除术后的五年生存率为27%。随后一份关于各类肉瘤肺转移外科治疗的报告显示，五年生存率为26%。本报告回顾了188例因各种癌肺转移而接受手术治疗患者的经验，表明通过手术切除这些转移灶可获得相似的生存率。共有188例患者因转移性肺癌接受了242次开胸手术。最常见的原发部位是结肠、黑色素瘤、乳腺和睾丸癌。当符合以下标准时，对这些转移灶进行手术治疗是合理的：（1）原发部位得到控制或可控制；（2）无肺外转移灶；（3）手术风险低；（4）非手术方法无有效治疗手段。
